Keyphrases
Risk Factors
100%
Epidemiology
82%
Confidence Interval
63%
Taiwan
60%
Nephrotic Syndrome
59%
Focal Segmental Glomerulosclerosis
55%
Acute Renal Failure
43%
Mesenchymal Stem Cells
42%
Taiwanese children
42%
End-stage Renal Disease
42%
Odds Ratio
41%
Urinary Tract Infection
40%
Population-based Cohort Study
38%
Chinese children
38%
Vesicoureteral Reflux
38%
Avascular Necrosis
38%
Liver Transplantation
38%
Successful Treatment
38%
Diffuse Mesangial Sclerosis
38%
Graft-versus-host Disease (GvHD)
38%
Totally Implantable Venous Access Port (TIVAP)
38%
Mortality Factors
38%
Steroid Resistance
34%
Continuous Ambulatory Peritoneal Dialysis
33%
Kidney Disease Progression
32%
High Incidence
32%
Taiwanese
31%
Eosinophilic Gastroenteritis
31%
Acute Rejection
30%
Methylprednisolone Pulse Therapy
30%
Heavy Proteinuria
30%
Proteinuria
29%
Hazard Ratio
28%
Peritoneal Dialysis Patients
27%
Renal Transplant Recipients
25%
Age Groups
25%
Prognostic Factors
25%
Autoimmune Disease
23%
Taipei
23%
Intestinal Transplantation
23%
Renal Transplantation
23%
Mesenchymal Stem Cell Transplantation
22%
Graft Function
22%
Transplantation
22%
Small Intestine
22%
Clinical Characteristics
21%
Pediatric Patients
21%
Multiorgan Transplantation
21%
Epithelial-to-mesenchymal Transition
20%
Therapeutic Effect
20%
Medicine and Dentistry
Cohort Effect
82%
Nephrotic Syndrome
62%
Acute Kidney Injury
62%
Proteinuria
56%
Kidney Graft
53%
Biopsy Technique
45%
End Stage Renal Disease
42%
Peritoneal Dialysis
40%
Urinary Tract Infection
40%
Avascular Necrosis
38%
Congenital Nephrotic Syndrome
38%
Vesicoureteral Reflux
38%
Chronic Kidney Disease
37%
Kidney Transplantation
36%
Focal Segmental Glomerulosclerosis
35%
Sclerosis
34%
Pediatrics
34%
Continuous Ambulatory Peritoneal Dialysis
33%
Acute Graft Rejection
33%
Diseases
32%
Transplantation
30%
Immunosuppressant
30%
Peritonitis
29%
Mesenchymal Stem Cell
28%
Vascular Access
28%
Systemic Lupus Erythematosus
25%
Prognostic Factor
24%
Autoimmune Disease
23%
Odds Ratio
22%
Podocyte
22%
Allograft
22%
Pediatrics Patient
21%
Multivisceral Transplantation
21%
Graft Versus Host Reaction
21%
Cohort Analysis
20%
Disease
20%
Panel Reactive Antibody
19%
Intestine Graft
19%
Mesenchymal Stem Cell Transplantation
19%
Partial Nephrectomy
19%
Xanthogranulomatous Pyelonephritis
19%
Staphylococcus Aureus
19%
Colon
19%
Therapy Effect
19%
Lupus Nephritis
19%
Cytokine
19%
Transitional Cell Carcinoma
19%
Hormone Response
19%
Nocturnal Enuresis
19%
Dextro Arginine
19%